RE:RE:So according to Trippdavewho wrote: James made it very clear that there are so many parts of the puzzle that are out of their control. So I can some what understand the string of past misses. It is hard to wait on other groups to get organised but Szls has little or no say in how they operate, how fast they can put it all together and when they start testing. TeleHealth is an excellent move in the mean time, way more direct control, cash paid up front and directly to rev./Q
Glad he took the time to discuss Exas. Their model is hugely expensive and time consuming to build out. Its possible ColonGuard may never generate profits. The rev gets eaten up by all the moving parts. Hence their fall from 124$US to 80$US IMO. If we were doing those 400k test numbers per Q like they are doing we would be floating in $ with our cost structure/model. Overall a good CC with no negative calls at the end.
IMO
I think you're missing the point. The point is... The tests are not getting out there. I am fairly confident, after the DD I've done, that StageZero is JHT and Meghan his assistant. Jerome is just a secondary financial "assistant" to the company. Try calling Tripp or anyone in the US. That will secure your investment. I wish everyone luck. I was optomistic for this stock for long time. But, after seeing this today, I am confident this stock wiill be sub 0.3-0.2 in no time.